Articles tagged with Respiratory Disorders
Scientists have created a genetically modified pig model that carries the mutated gene responsible for cystic fibrosis, mimicking lung disease in humans. This breakthrough could lead to better understanding of the disease and development of new treatments.
The Kansas State University researchers are analyzing data from feedlots to create decision-making tools for managing bovine respiratory disease complex. They hope to generate estimates of the effect of certain risk factors and develop a system to classify distributions of disease events within feedlot pens.
A recent study found that routine intake of dairy products can lower the instance of gum disease. The American Academy of Periodontology suggests that consuming dairy products like milk, cheese, and yogurt may help achieve a healthy lifestyle, including a healthy mouth.
A new study published in Current Biology confirms the disease threat facing great apes, finding evidence of virus transmission from humans to wild apes. The study also shows that research and tourism projects have suppressed poaching of chimpanzees, outweighing mortality caused by human disease introduction.
A new system has been developed to classify rare lung diseases in infants, improving diagnosis and treatment outcomes. The system groups various lung diseases into distinct categories, allowing pathologists to diagnose children's lung disease more accurately.
Virginia Commonwealth University researchers have discovered a new mechanism to inhibit key enzymes involved in clotting disorders. The newly designed molecules, known as sulfated DHPs, show promise in preventing thrombin and factor Xa's critical action.
MedImmune will present three abstracts at the AAP National Conference & Exhibition, including cost-effectiveness data for palivizumab prophylaxis among preterm infants. The company's surveillance program aims to track RSV activity nationwide and inform improved prevention guidelines.
A Canadian study found that high-dose ibuprofen can slow the decline of lung function in children with mild cystic fibrosis. The treatment reduced hospital stays and improved quality of life for patients.
A study in Great Britain found that even low levels of air pollution boost the chances of an early death, especially from respiratory diseases. The research, which spanned over 16 years, revealed strong links between black smoke and sulphur dioxide with increased risk of mortality.
Survival rates for individuals with scleroderma have increased by 12% over the past 30 years, from 54% to 66%, thanks in part to advancements in treatment. Newer medications such as ACE inhibitors have dramatically improved outcomes for patients, particularly in reducing renal crisis mortality.
A new reovirus has been isolated from bats and can cause a serious but non-fatal respiratory illness in humans. The virus, named Melaka, is closely related to two other bat-borne reoviruses and can be transmitted between people.
Research from Dana-Farber Cancer Institute reveals that Black Americans are less certain about lung cancer prevention recommendations and more fearful of symptoms evaluation, potentially delaying treatment. This fatalism may contribute to Black patients being diagnosed with advanced stages of the disease.
Researchers identify distinct genetic profile associated with rapid progression of IPF, highlighting the need for targeted therapies and closer monitoring. The study's findings may lead to the development of biomarkers for disease progression and more effective treatment strategies.
A subset of patients with idiopathic pulmonary fibrosis (IPF) has been found to have a short duration of symptoms before diagnosis and an accelerated clinical course to end-stage disease. This 'rapid progressor' group is characterized by distinct gene expression patterns, which may lead to the development of new therapeutic interventions.
A Mayo Clinic study found a significant association between rheumatoid arthritis and chronic lung diseases, with cumulative incidence rates increasing over time. The study followed 603 patients with RA for up to 30 years, revealing higher rates of obstructive lung disease and diffuse parenchymal infiltrative lung disease.
Researchers have identified unique expression domains for two proteins, SPLUNC1 and SPLUNC2, in the lungs of people with cystic fibrosis. The discovery could help understand the immune system's role in the disease and potentially prevent lung damage.
A study of 4,181 adults found anxiety disorders independently associated with several physical conditions, increasing disability risk. Anxiety disorders were also linked to poorer quality of life in individuals with both conditions.
A randomized clinical trial has proven that a drug can slow down deterioration of lung function in scleroderma patients. Participants who received treatment had a small but statistically significant improvement in lung function and less shortness of breath compared to those who were not treated.
Research highlights the threat of biological diversity loss to human health, citing Lyme disease and West Nile virus as examples. A rapid autopsy program for a rare lung disease called interstitial pulmonary fibrosis (IPF) also improves medical research outcomes.
The National Institutes of Health (NIH) has launched a $71 million effort to investigate rare diseases affecting fewer than 200,000 persons in the US. The Clinical Research Consortium Network (RDCRN) aims to develop personalized treatments and prevent complications through genetic research.
The Broad Institute scientists will survey DNA of 50,000 individuals using large-scale genotyping technologies and advanced informatics to highlight genetic differences in specific genes. The project aims to accelerate the pace of identifying risk factors and genetic variants associated with human diseases.
Researchers have identified novel drug therapies, including endothelin antagonists and prostacyclin, that improve quality and quantity of life for patients with PAH. These treatments offer hope for patients who previously faced lung transplantation.
A study found that elevated BNP levels are associated with increased mortality and significant pulmonary hypertension in patients with chronic lung disease. Pulmonary artery pressure above 35 mmHg is a key indicator of this condition.
Fine particulate matter exposure (PM2.5) was associated with short-term increases in hospital admission rates for all health outcomes except injuries. Cardiovascular risks were highest in Eastern US counties, with a 1.28% increase in heart failure risk per 10-µg/m3 PM2.5.
A 14-year study published in Annals of Internal Medicine found that quitting smoking can add years to life. The study showed a significant reduction in death rates among participants who quit compared to those who continued to smoke.
Researchers identify specific T cells and staining methods that improve detection and treatment of RA lung disease. The study suggests therapies targeting T cell function may succeed in treating RA lung disease, while early detection could lead to prolonged lives for patients.
A study of 2500 babies found no difference in outcomes between those who received suctioning and those who did not, challenging current guidelines on perinatal treatment. The results suggest that routine suctioning may not be effective in preventing meconium aspiration syndrome (MAS) or its complications.
Researchers have identified six essential genes for cilia formation in humans, which could help diagnose and treat diseases such as infertility, pulmonary diseases, and vision problems. The discovery provides a critical new tool for medical researchers to understand the genetic basis of these disorders.
New studies release at the American Urological Association (AUA) show Enablex significantly reducing overactive bladder symptoms, including incontinence episodes and nocturia. Enablex improved efficacy parameters associated with OAB without CNS or CV safety concerns.
A genetic mutation in the ABCA3 gene is linked to severe surfactant deficiency in infants, leading to fatal lung disease. Researchers found mutations in 16 infants, with 15 dying from their illness, and discovered a potential mechanism for the defective transport of phospholipids critical for surfactant function.
A study found that nitric oxide can prevent lung disease and death in premature infants by reducing the risk of severe bleeding into the brain. The treatment, which involves adding small amounts of nitric oxide to oxygen, has been shown to improve survival rates and reduce the need for long-term ventilation.
The NIH has established a network of clinical research centers focused on rare diseases, aiming to accelerate diagnosis and treatment. The RDCRCs will facilitate data sharing and collaboration among investigators and patient support groups to improve lives and potentially prevent or eliminate these diseases.
A $12 million NIH grant will support interdisciplinary research on lung diseases in New Hampshire, including lung cancer and cystic fibrosis. The funding will also create infrastructure for state-of-the-art research and jobs in the local economy.
The Medicare waiting period affects 1.26 million seriously disabled Americans, with 400,000 having no health insurance. Eliminating the two-year wait could save states $1.8 billion per year and reduce federal Medicaid expenditures by $2.5 billion.
Stanford is conducting an online self-management program for individuals with heart disease, lung disease, and type-II diabetes. The program aims to improve health outcomes by teaching participants how to manage their conditions effectively, including managing medications, exercise, and stress.
The American Thoracic Society has named two Department of Veterans Affairs clinician-scientists, Rabih I. Bechara and Pierre P. Massion, as the first recipients of its Research Career Development Award. The award will provide $20,000 per year for three years to support their research on respiratory diseases.
Researchers found alterations in airway structure due to cigarette smoke exposure in utero may cause symptoms and abnormal lung function in exposed infants. A potential therapy for premature babies with bronchopulmonary dysplasia has been identified as low molecular weight catalytic antioxidant.
Research at Ohio State University found that listening to music while exercising increased walking distance by an average of 445 feet among patients with severe lung disease. The study suggests that music can help distract from physical symptoms and improve overall fitness levels, leading to better independence in daily activities.
A study of 262 climbers found that three out of four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb. This suggests a significant risk of the disorder among climbers, highlighting the need for better markers and methods to identify individuals at risk.
Researchers investigate phenotypic variability in cystic fibrosis, revealing its impact on disease progression and treatment outcomes. The study highlights the importance of personalized medicine approaches to better manage CF patients.
Researchers at University of North Carolina at Chapel Hill School of Medicine believe they have solved a key part of the cystic fibrosis puzzle by finding that there's too little salt in patients' lungs. Long-lasting treatments may be needed to reverse the disease and improve symptoms.
A new study by the National Institute of Child Health and Human Development found that early postnatal doses of dexamethasone may increase the risk of intestinal perforation in extremely low birth weight infants. The treatment was not shown to prevent chronic lung disease or improve survival rates.
Scientists at UCSF discovered a single defect in a protein causes severe auto-immune disease resembling lupus, affecting 100,000 people in the US. The finding provides evidence that lupus might be an inherited disease with a simple genetic root, rather than multiple genetic defects.
Researchers at Vanderbilt University Medical Center have identified a new drug therapy that appears to be effective in reversing symptoms of Ménétrier's disease, a rare and premalignant stomach disorder. The treatment, which blocks activation of the EGF receptor, showed promising results in a patient with severe vomiting and protein loss.
A Phase III study found that Aslera significantly improved disease activity and symptoms in patients with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The treatment also showed benefits for bone mineral density, particularly in women on steroids.
Researchers have identified a genetic cause for immunoglobulin A nephropathy (IgAN), the most common form of glomerulonephritis worldwide. The gene, located on chromosome 6, is linked to the disease in about 60% of families studied.
A University of California, San Francisco study found that the herbal supplement PC-SPES significantly reduces PSA levels in men with hormone-independent disease, providing a new treatment option. The study also shows promise for shrinking tumors and improving quality of life.
New research found that 13 of 50 people with primary pulmonary hypertension shared a genetic defect in the BMPR-II gene, similar to those with familial forms. This discovery has important implications for treatment and future therapies focused on altered cell signals.
The University of North Carolina School of Medicine has received a $5 million federal grant to investigate ANCA vasculitis, a disease causing small blood vessel inflammation. Researchers will explore the cause of the disease and develop better treatments.
A Chimpanzee Genome Project is proposed due to the remarkable differences in diseases affecting humans and chimps. The project aims to identify genetic factors contributing to these disparities, which could lead to better treatments for both humans and captive apes.
A UBC research team led by Prof. Chris Overall discovered a protein that reduces inflammation and halts the flow of white blood cells. The discovery, published in Science, may lead to new treatments for chronic inflammatory diseases such as arthritis and lung disease.
Two separate groups of scientists identified a genetic mutation associated with primary pulmonary hypertension (PPH), a rare but devastating lung disease. Defects in the BMPR2 gene lead to abnormal proliferation of cells in the lungs characteristic of PPH.
Researchers have identified a gene associated with inherited primary pulmonary hypertension, providing new avenues of study for determining its molecular basis. The discovery opens up possibilities for designing more effective therapies for this devastating condition, which affects primarily women of childbearing age.
A recent study published in the Journal of Periodontology found that smoking is responsible for more than half of periodontal disease cases among adults in the US. Quitting smoking can gradually erase the harmful effects on periodontal health.
A Cornell University study reveals that a naturally occurring disease can regulate a wildlife population, with house finches experiencing a dramatic drop in numbers after an epidemic began. The research provides insight into the dynamics of other host/disease systems and has implications for understanding diseases like AIDS.
A prospective cohort study found that regular exercise can benefit men with type 2 diabetes, while low physical fitness is associated with mortality. Meanwhile, a dangerous combination of blood thinners and intravenous steroids requires daily monitoring to prevent life-threatening bleeding.
A study conducted by researchers at Cincinnati Children's Hospital Medical Center shows that nearly 75 percent of children with severe juvenile rheumatoid arthritis respond dramatically to ENBREL (etanercept). The drug eases joint pain and swelling, enhances mobility, and improves disease activity for patients.
A recent study found that the genetic marker associated with periodontal disease in people of European heritage is barely present in Chinese populations. This suggests that oral hygiene habits, smoking, and other risk factors may be more important in explaining the high prevalence of periodontal disease in Chinese populations.
Global warming accelerates human disease outbreaks, malnutrition, and environmental degradation due to increased pollution and crop losses. As populations grow, crowded cities will become breeding grounds for diseases like dengue fever, while waterborne illnesses spread unchecked.
New research published in Gut journal found no evidence that measles virus is associated with Crohn's disease. The study isolated particles from the gut tissue of patients and compared them to healthy tissue samples, but found high levels of related cells in all types of samples.